Concerns Raised Over Melatonin Use in Children Amid Research Findings

Sleep disturbances affect approximately one-third of young people globally, prompting many families to turn to melatonin for relief. Despite its common perception as a safe sleep aid, a new analysis published in JAMA Network Open indicates that significant questions remain regarding melatonin’s impact on developing sleep systems.

Dr. Seixas, an expert in psychiatry and behavioral sciences, reviewed new studies that examined the relationship between melatonin use and sleep architecture in children. These studies reveal reassuring findings but also highlight a demand for evidence-based approaches in pediatric sleep care.

Melatonin use has surged among children and adolescents, with nearly one in five preteens and school-aged children reportedly using it within the last month, according to national survey data. This use has doubled from 2017 to 2020, as families face limited access to sleep specialists and behavioral interventions.

Dr. Seixas urges caution regarding pediatric melatonin use. In the United States, melatonin is classified as a dietary supplement rather than a pharmaceutical, which subjects it to less stringent oversight. Current long-term safety data is limited, and while melatonin may benefit children with neurodevelopmental disorders, efficacy trials in typically developing children are scarce.

A referenced study analyzed data from 684 children referred to a pediatric sleep lab, comparing those who had used melatonin to nonusers. The results showed that melatonin users had a slightly lower percentage of rapid eye movement (REM) sleep, accounting for 16.7% of total sleep compared to 19% for nonusers. However, the study found no significant differences in 14 other sleep measures.

Despite these findings, Dr. Seixas cautions against interpreting the absence of major differences as proof of safety for routine melatonin use in children. He highlights the importance of REM sleep, which plays a crucial role in emotional memory, learning, and brain development, especially during childhood and adolescence.

Melatonin is better described as a “chronobiotic” that regulates circadian timing rather than a straightforward sleep aid. Its effects depend on various factors including dosage, timing, formulation, and individual differences in biological clocks. Future research must delve into melatonin’s effects on sleep onset and its long-term implications for sleep architecture and neurodevelopment.

Dr. Seixas advocates for personalized approaches to sleep issues, differentiating between various underlying causes. Melatonin may be beneficial when used under clinical guidance for specific sleep disorders and combined with behavioral interventions.

The findings also point to challenges within the healthcare system, as the rising popularity of melatonin reflects a lack of accessible, affordable sleep care alternatives. Families often endure long waits for sleep specialists, and behavioral programs are not widely available.

In summary, while the study suggests that melatonin does not significantly disrupt sleep architecture, it should not be universally prescribed. Dr. Seixas emphasizes the need for guided use, targeted treatment strategies, and increased investment in pediatric sleep health resources. Enhanced standards and public education could further assure effective and developmentally appropriate interventions for children.